SLNO icon

Soleno Therapeutics

18 hedge funds and large institutions have $22.2M invested in Soleno Therapeutics in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
18
Holders Change
+8
Holders Change %
+80%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
5
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$10.2M 4,359,683 +326,149 +8%
OIM
2
Oracle Investment Management
Connecticut
$5.71M 2,438,060 +50,000 +2%
6CM
3
683 Capital Management
New York
$1.98M 844,112
SM
4
Sabby Management
Florida
$1.84M 785,955 -131,880 -14%
BC
5
Birchview Capital
Vermont
$1.59M 678,428
TMC
6
Trellus Management Company
Florida
$302K 129,243 +129,243 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$119K 50,794 +907 +2%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$104K 44,364 +44,364 New
BlackRock
9
BlackRock
New York
$93K 39,761 +24,162 +155%
KC
10
Kepos Capital
New York
$88K 37,591 +37,591 New
VF
11
Virtu Financial
New York
$42K 18,150 +18,150 New
Citadel Advisors
12
Citadel Advisors
Florida
$30K 12,926 +12,926 New
Northern Trust
13
Northern Trust
Illinois
$27K 11,630 +11,630 New
SAM
14
Shikiar Asset Management
New York
$23K 10,000 +10,000 New
Deutsche Bank
15
Deutsche Bank
Germany
$13K 5,608 +5,608 New
PAM
16
Panagora Asset Management
Massachusetts
$11K 4,654 +4,654 New
UBS Group
17
UBS Group
Switzerland
$9K 3,975 +1,600 +67%
DZ Bank
18
DZ Bank
Germany
-118,801 Closed
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$0 1